235 related articles for article (PubMed ID: 21573497)
1. Synergism between K-rasVal12 and mutant Apc accelerates murine large intestinal tumourigenesis.
Luo F; Poulogiannis G; Ye H; Hamoudi R; Arends MJ
Oncol Rep; 2011 Jul; 26(1):125-33. PubMed ID: 21573497
[TBL] [Abstract][Full Text] [Related]
2. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Int J Exp Pathol; 2009 Oct; 90(5):558-74. PubMed ID: 19765110
[TBL] [Abstract][Full Text] [Related]
3. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
[TBL] [Abstract][Full Text] [Related]
4. Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability.
Luo F; Poulogiannis G; Ye H; Hamoudi R; Zhang W; Dong G; Arends MJ
J Pathol; 2011 Feb; 223(3):390-9. PubMed ID: 21171084
[TBL] [Abstract][Full Text] [Related]
5. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation.
Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ
J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880
[TBL] [Abstract][Full Text] [Related]
6. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
7. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia.
Kim SH; Roth KA; Moser AR; Gordon JI
J Cell Biol; 1993 Nov; 123(4):877-93. PubMed ID: 8227147
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
[TBL] [Abstract][Full Text] [Related]
11. WNT signaling controls expression of pro-apoptotic BOK and BAX in intestinal cancer.
Zeilstra J; Joosten SP; Wensveen FM; Dessing MC; Schütze DM; Eldering E; Spaargaren M; Pals ST
Biochem Biophys Res Commun; 2011 Mar; 406(1):1-6. PubMed ID: 21184732
[TBL] [Abstract][Full Text] [Related]
12. The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine.
Patek CE; Arends MJ; Rose L; Luo F; Walker M; Devenney PS; Berry RL; Lawrence NJ; Ridgway RA; Sansom OJ; Hooper ML
BMC Gastroenterol; 2008 Jun; 8():24. PubMed ID: 18554389
[TBL] [Abstract][Full Text] [Related]
13. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
14. Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation.
Martinez G; Wijesinghe M; Turner K; Abud HE; Taketo MM; Noda T; Robinson ML; de Iongh RU
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4794-806. PubMed ID: 19515997
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
Koehl GE; Spitzner M; Ousingsawat J; Schreiber R; Geissler EK; Kunzelmann K
Oncogene; 2010 Mar; 29(10):1553-60. PubMed ID: 19966863
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes.
Abraham SC; Park SJ; Lee JH; Mugartegui L; Wu TT
Mod Pathol; 2003 Aug; 16(8):786-95. PubMed ID: 12920223
[TBL] [Abstract][Full Text] [Related]
18. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
[TBL] [Abstract][Full Text] [Related]
19. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
20. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88.
Rakoff-Nahoum S; Medzhitov R
Science; 2007 Jul; 317(5834):124-7. PubMed ID: 17615359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]